Pioneering Cystic Fibrosis Drug Therapies: Gairdner Award for Drs. Negulescu & Welsh
[HPP] Michael J. WelshApril 11, 20253 min
8 connections·13 entities in this video→Understanding Cystic Fibrosis
- 🔬 Dr. Michael Welsh, a physician scientist at the University of Iowa, dedicated his research to understanding cystic fibrosis (CF), particularly the lung disease aspect.
- 💡 His initial focus was on how the lung controls liquid in the airway and identifying what goes wrong in CF patients to cause lung disease.
- 🧬 The research aimed to understand the defective gene that gives wrong instructions for building a protein, leading to the disease.
Breakthrough Discoveries
- 🧪 Early experiments involved inserting a normal copy of the defective gene into a CF cell to observe if it could restore normal function.
- 🔑 The CFTR protein, when functional, forms a pore or channel in the cell membrane, allowing chloride to flow.
- ❄️ A pivotal experiment showed that simply cooling down CF cells could make the defective protein open, suggesting a drug could achieve a similar effect.
Developing Transformative Therapies
- 💊 Dr. Paul Negulescu, from Vertex Pharmaceuticals, played a crucial role in developing small molecule drugs (tablets or pills).
- ✨ These drugs were designed to restore the function of the defective protein that causes cystic fibrosis.
- 🎯 This achievement was remarkable, as restoring function to a protein caused by a genetic defect was previously believed to be impossible.
Impact and Recognition
- ✅ Current medications developed from this research can now treat approximately 90% of individuals with CF.
- 🏆 Drs. Welsh and Negulescu were awarded the Canada Gairdner International Award, an incredible honor that recognizes the work of thousands of people.
- 👏 The award is seen as a testament to the entire team's dedication and collaborative efforts over many years.
Collaborative Roots of Discovery
- 🇨🇦 The discovery of the CF gene itself was a result of a significant collaboration between Canadian scientists at Sick Kids in Toronto and US scientists at the University of Michigan.
- 🤝 This cross-border research highlights the importance of international collaboration in medical breakthroughs.
- 💖 The Canadian connection makes receiving the Canada Gairdner International Award particularly meaningful to the laureates.
Knowledge graph13 entities · 8 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover · drag to explore
13 entities
Chapters1 moments
Key Moments
Transcript12 segments
Full Transcript
Topics12 themes
What’s Discussed
Cystic FibrosisGenetic DiseaseLung DiseaseCFTR GeneChloride ChannelsSmall Molecule DrugsDrug DevelopmentProtein Function RestorationCanada Gairdner International AwardMedical ResearchPhysician ScientistsCollaborative Research
Smart Objects13 · 8 links
Concepts· 3
People· 2
Companies· 4
Event· 1
Product· 1
Locations· 2